Skip to main content
Figure 7 | BMC Cancer

Figure 7

From: A novel engineered VEGF blocker with an excellent pharmacokinetic profile and robust anti-tumor activity

Figure 7

H&E staining analysis. H&E staining for HB-002.1 treated tumor sections at low dose (5 mg/kg) was presented and compared to that of PBS treated group. Large regions of tumor necrosis were observed in Colo-205 (A) as well as A549 (B) tumor sections respectively. Representative fields of H&E staining are shown at 4x (A) and 20x (B) magnification for Colo-205 and A549 tumor sections, respectively.

Back to article page